Vaxneuvance 0.5 ML syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F91YA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,222
Award facts
- Contract value 100% obligated
- $11,222.26 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 22, 2026, for the supply of Vaxneuvance 0.5 mL syringes valued at $11,222.26. The contract is a firm fixed-price delivery order with an ultimate completion date of January 23, 2026, and will be performed at the awardee's location in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly for military and veteran healthcare systems.
This delivery order represents a task order under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., holds a larger IDC with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. Through these overarching contract vehicles, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical commodities—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs worldwide and serve customers including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26F91YA?
SPE2DR26F91YA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F91YA worth?
The government has obligated $11,222 on SPE2DR26F91YA.
Is contract SPE2DR26F91YA an order under another contract?
Yes. SPE2DR26F91YA is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F91YA competed?
The extent of competition for SPE2DR26F91YA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award